Elipovimab |
| Catalog No.GC72470 |
Elipovimab est un anticorps anti-vih-1 puissant et largement neutralisant pour l’élimination ciblée des cellules infectées par le vih.références :.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2101210-43-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells
References:
[1]. Caroline Thue Hvilsom, et al. TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure. Front Immunol. 2021 Sep 23;12:704617.
Review for Elipovimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Elipovimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *